Community Pharmacies

Andrew George Excerpts

Tuesday 2nd June 2026 Westminster Hall

[Andrew George (St Ives) (LD)]

I congratulate my hon. Friend the Member for Tiverton and Minehead (Rachel Gilmour) not only on securing this debate, but on the manner in which she introduced it. As a member of the Health and Social Care Committee, which keeps this and other issues under constant review, I have been listening very intently today, and I will certainly be taking messages back to the Committee. I particularly welcomed the contribution of the hon. Member for North Somerset (Sadik Al-Hassan) and his—pardon the pun—prescription for the better health of pharmacies.

I welcomed the announcement in the Minister’s written statement to the House yesterday, but it is notable that Community Pharmacy England has said that even with that extra investment, many community pharmacies will remain in financial peril. Although it softens the blow, it will not remove the threat or the peril hanging over many pharmacies around the country.

As for my constituency, there are 15 pharmacies in west Cornwall and the Isles of Scilly, which seems to be about average compared with other constituencies that have been mentioned, and Pharmacy First saves approximately 2,500 GP appointments per annum. That initiative is certainly delivering but, as previous speakers have said, it could deliver a great deal more.

It is telling of the times we live in that one of the tragically many pharmacies that have closed—I will not say where—has been replaced with an apothecary. I hope that that is not a sign of a continuing trend, but perhaps it says something symbolic about the way things are going. We are well aware that pharmacies should be at the frontline of one of the most important of the Government’s three shifts: the shift from hospital to community. Building up and strengthening the resilience of our community pharmacies is essential for the Government to deliver that shift.

One of the many brilliant community pharmacies in my constituency is Hall’s in Helston, in the south of the constituency. The pharmacy dispenses between 9,000 and 12,000 prescriptions per month, representing about 70% of the dispensing activity in the hinterland of the Helston area. Despite that critical role in primary care delivery, it is under increasingly severe financial pressure. It does not believe that yesterday’s announcement will relieve that pressure, because of how medicines are reimbursed.

As others have said, a key issue is the growing number of medicines that are being priced above the drug tariff. Essential medications, such as—I will get the pronunciation wrong—ramipril, bisoprolol and Creon are frequently being supplied at a loss. Price concessions are sometimes introduced, but they are often delayed, inconsistent and insufficient to reflect real-time market prices.

That creates a situation in which pharmacies must either dispense at a financial loss or deny supply. They use a system called e-CASS, which tracks real-time drug pricing. On any given day, there are between 16 and 40 lines that cannot be ordered through standard systems because the purchase price exceeds the reimbursement tariff. That number has increased significantly over recent years, indicating a worsening trend. As a result, independent pharmacies such as Hall’s are increasingly being forced to subsidise NHS dispensing from their own funds just to maintain patient care. That is simply not sustainable.

The situation is further complicated by ongoing medicine shortages. There are growing concerns that elements of the current reimbursement system are actively impacting timely patient access to medicines. Pharmacies are left simultaneously managing supply chain disruptions and financial risks, with limited systemic support.

We are also witnessing troubling behaviour in the sector. Some large corporate pharmacy chains are redirecting patients to independent pharmacies for medicines that are above tariff, incorrectly stating that those medicines are unavailable when in reality they are unwilling to supply them because of the financial loss involved. That shifts both the clinical and the financial burden on to independent contractors. Regrettably, that has begun to force difficult decisions across the sector as more medicines fall off tariff.

In addition, the continued closure of pharmacies is placing further strain on other parts of the NHS. It is putting further pressure on emergency departments and GP services, which is the exact opposite of the direction in which services should be going.